Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PTO DECISION TO ALLOW GENE FRAGMENT PATENTS IS "APPALLING," U. WASHINGTON's HOOD TELLS AAAS; PTO OFFICIAL SAYS ISSUE IS "OBVIOUSNESS," NOT "UTILITY" OF ESTs

Executive Summary

Broad changes in the patent system may be necessary to cope with advances in medical research, University of Washington researcher Leroy Hood remarked during the American Association for the Advancement of Science annual meeting in Seattle Feb. 14.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029771

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel